Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic science behind the catastrophic epilepsies.

Jong M Rho1

  • 1Departments of Pediatrics and Neurology, College of Medicine, University of California at Irvine Medical Center, 101 The CityDrive S., Orange, CA 92868, U.S.A. jmrho@uci.edu

Epilepsia
|July 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptom impact and safety of ketogenic therapy in adults with anorexia nervosa: a feasibility trial.

Communications medicine·2026
Same author

The Interplay between the Gut and Ketogenic Diets in Health and Disease.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Vigabatrin Versus Adrenocorticotropic Hormone After High-Dose Prednisolone Failure for the Treatment of Epileptic Spasms.

Journal of child neurology·2025
Same author

An international survey on withdrawing the ketogenic diet therapy for epilepsy.

Epilepsy & behavior : E&B·2025
Same author

Mutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice.

The Journal of clinical investigation·2025
Same author

Role of cholesterol in modulating brain hyperexcitability.

Epilepsia·2024
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

Catastrophic childhood epilepsies like infantile spasms are difficult to treat and poorly understood. Research highlights three key hypotheses—CRH, NMDA, and serotonin-kynurenine—for infantile spasms, potentially informing later epilepsy types.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neuroscience

Background:

  • Childhood catastrophic epilepsies, including infantile spasms, Lennox-Gastaut syndrome, and PMEs, are treatment-resistant and cause severe neurodevelopmental deficits.
  • Current understanding of the pathophysiology of these severe epilepsy syndromes is limited.
  • Lack of appropriate animal models hinders research into mechanisms and therapeutic targets.

Purpose of the Study:

  • To review current hypotheses on the pathophysiology of infantile spasms.
  • To explore potential links between infantile spasms' mechanisms and later-onset catastrophic epilepsies.
  • To emphasize the need for better animal models for developmental encephalopathic epilepsies.

Main Methods:

  • Review of recent clinical and basic science investigations.

Related Experiment Videos

  • Analysis of three major hypotheses for infantile spasms pathophysiology: CRH, NMDA, and serotonin-kynurenine.
  • Discussion of the relevance of these hypotheses to later-onset catastrophic epilepsies.

    • Main Results:

    • Three primary hypotheses for infantile spasms pathogenesis are presented: corticotropin-releasing hormone (CRH), N-methyl-D-aspartate (NMDA), and serotonin-kynurenine.
    • These mechanisms may partially explain later-onset catastrophic epilepsies, as infantile spasms can persist.
    • A significant need exists for improved animal models of developmental encephalopathic epilepsies.

    Conclusions:

    • Understanding the pathophysiology of catastrophic childhood epilepsies requires further investigation into mechanisms like CRH, NMDA, and serotonin-kynurenine pathways.
    • Developing more accurate animal models is crucial for advancing therapeutic strategies for these severe neurological disorders.
    • Bridging the gap between infantile spasms and later epilepsy forms through mechanistic insights is a key research direction.